WST

As of 2026-09-10, WST scores 49out of 100 on QNTM’s five-factor quantitative model, a moderate conviction reading. The score blends momentum, quality, volume, value and sentiment, then adjusts for the current macro regime. WST trades at $344.25, 69% above the band ceiling.

WST scores 49 out of 100 on QNTM's five-factor model — a moderate reading — neither strongly favored nor flagged for weakness at 49. Its strongest factor is momentum at 57 (solid), where price trend and relative strength are working in its favor, followed by sentiment at 48. The weakest is volume at 45, where volume gives little confirmation. Among Healthcare stocks it ranks in roughly the top 39% of the Healthcare names the model scores.

On valuation, WST is priced near the top of its recent range — the rich end on the model's valuation read. The five factors sit close together, so the composite reflects a balanced profile rather than one dominant driver. The blended composite before the macro overlay was 50. Same-sector names the model rates nearby include HALO, THC, TGTX.

This is a descriptive factor read on WST, recomputed each trading day and shown with its reasoning — not a recommendation to buy, hold or sell. The score reflects where WST sits on the model's measures today, and can change as new data arrives.

FACTOR BREAKDOWN

VALUATION RANGE

QNTM’s descriptive fair-value band for WST runs $148.51–$203.21. Current price $344.25 sits 69% above the band ceiling. This is valuation context, not a price target.

OTHER HEALTHCARE NAMES

QNTM provides quantitative model outputs for informational and educational purposes only. It is not investment advice and QNTM is not a registered investment adviser. Scores are rankings, not buy/sell recommendations. Data as of 2026-09-10.